Introduction:
Heart disease (HD) remains the major cause of death and disability in the United States. Numerous strategies, both pharmacological and invasive, have been developed to reduce the enormous toll of this disease. One of the most effective, but least utilized strategy is cardiac rehabilitation (CR). CR has been shown to to reduce cardiac mortality by 31%, all-cause mortality by 27%, and improve cardiac function, blood pressure, left ventricular function, and quality of life in patients with HD. Although CR is a multifaceted program, its mainstay is treadmill walking at a sufficient intensity to improve cardiac function and peripheral muscle conditioning and endurance. Intensity is determined by establishing a target heart rate (THR) based on a pre-rehabilitation cardiac stress test. Unfortunately, the exercise demands of CR may exceed the capabilities of the patient with intermittent claudication (IC), depriving the patient of optimal benefit and reduction in risk for future major cardiac event (MACE).
The primary purpose of this study was to determine whether PAD or IC interferes with the successful completion of CR and cardiac risk reduction. The secondary purpose was to evaluate through Markov decision analysis whether the invasive treatment of IC is indicated in those patients unable to successfully complete CR.
Methods:
Study Population: To determine whether IC interferes with the successful completion of CR, the records of 230 consecutive patients who began a supervised CR program at Advocate Lutheran General Hospital were reviewed. Demographic information, type of cardiac impairment, program attendance, and THR performance were recorded.
Conclusions:
1. PAD is a significant cause of CR failure.
2. Despite the small risks of intervention, there is a clear indication for invasive treatment in the subgroup of patients with IC, known ischemic heart disease, and the inability to successfully complete CR.
Results:
Markov Analysis of Treatment Strategies: In a hypothetical cohort of 10,000 patients, the selective strategy, in which ABI measurement is performed for patients who fail CR, followed by a diagnostic work-up and revascularization for IC if needed, yielded a lower number of fatal events compared with the base and comprehensive strategies. Although the selective strategy included more fatal peri-procedural events due to the revascularization procedures, the reduction in the number of fatal cardiac events outweighed the total number of fatal procedure-related deaths, saving an additional 54 lives compared with the base strategy.
Sensitivity analysis revealed that the selective strategy remained the best treatment option if the probability of fatal peri-procedural events was < 8%. If this probability was > 8%, the base strategy was preferred. CABG, coronary artery bypass grafting; CHF, congestive heart failure; CR, cardiac rehabilitation; MI, myocardial infarction; PTCA, percutaneous transluminal coronary angioplasty; SD, standard deviation. We assumed that IC might interfere with the successful completion of CR by causing the patient to prematurely discontinue participation because of calf discomfort while walking or by limiting the patient's walking effort, which would manifest as failure to reach THR.
For the purposes of this study, CR failure was defined as the the completion of < 32 sessions or an inability to reach THR during the performance of supervised exercise during the 36 session time frame.
Atherosclerotic Plaque 
IC and CR Failure:
The records of 230 consecutive patients undergoing CR were reviewed. Of these, 126 had also completed a WIQ. Figure 6 summarizes the patient characteristics and severity of cardiac disease. PAD was present according to the WIQ claudication symptoms data in 29%, by the WIQ walking distance score in 24%, and by ABI in 26%. Based on the definitions of success and failure, 75 of 126 patients (60%) successfully completed CR and 51 (40%) failed. Failure was significantly more common in patients with claudication (76%) than in those without (26%; odds ratio [OR], 8.9; 95% confidence interval [CI] , 3.7-21.7; P < .001). The presence of PAD, determined by the WIQ walking distance score, was significantly higher in the failure group (34%) versus the success group (17%; OR, 2.5; 95% CI, 1.1-6.0; P = .03). The presence of PAD determined by ABI was higher in the failure group (39%) versus the success group (14%; OR, 3.8; 95% CI, 0.8-17.9; P = .08) . Logistic regression analysis when cardiac rehab failure was adjusted for age and gender was significantly associated with the presence of PAD based on WIQ walking distance score (OR, 2.8; 95% CI 1.1-7.1; P = .03).
Model Structure: A Markov decision model was developed to compare fatal events of three treatment strategies (base, selective, comprehensive) for patients requiring CR.
Treatment Strategies :
The base strategy models current CR practice trends. Patients unable to adequately ambulate to meet THR undergo no further treatment. In the selective strategy, patients unable to sufficiently ambulate to meet THR underwent evaluation for IC with ABI measurement and if indicated, angiography. If PAD is documented, then the lesion is treated with percutaneous transluminal angioplasty (PTA) or bypass grafting. The comprehensive strategy involves the screening, diagnosis, and treatment of IC for every patient before the initiation of CR.
Evaluation of PAD:
The presence and extent of PAD and IC were assessed by the Walking Impairment Questionnaire (WIQ) and, in a subset of patients, calculation of the ankle-brachial index (ABI). The WIQ was obtained by self-administration or telephone interview. The ABI was measured with a hand-held Doppler probe and a random-zero sphygmomanometer. The leg with the lowest ABI was used in the analyses. The presence of PAD was defined as an ABI of < 0.90. Cardiac event = acute angina or myocardial infarction ABI = Ankle-Brachial index; PAD = Peripheral Arterial Disease; CR = Cardiac Rehabilitation
